Respiratory Devices Market
Respiratory Devices Market Forecasts to 2030 - Global Analysis By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices and Consumables & Accessories), Disease/Disorder (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Cystic Fibrosis, Neonatal Respiratory Distress Syndrome and Other Respiratory Disorders), End User and By Geography
According to Stratistics MRC, the Global Respiratory Devices Market is accounted for $22.7 billion in 2024 and is expected to reach $40.9 billion by 2030, growing at a CAGR of 10.3% during the forecast period. Respiratory devices are medical instruments used to assist or support breathing in patients with respiratory conditions. These devices provide mechanical ventilation for patients who cannot breathe independently, and oxygen therapy equipment, which delivers supplemental oxygen. Respiratory devices are critical in both acute and chronic settings, enhancing respiratory function, ensuring adequate oxygenation, and improving patient outcomes.
According to the WHO, in 2019, about 262 million people were suffering and 0.5 million people died from asthma.
Market Dynamics:
Driver:
Rising prevalence of chronic obstructive pulmonary disease (COPD)
COPD, a leading cause of morbidity and mortality worldwide, increases the demand for various respiratory devices such as ventilators, oxygen concentrators, and nebulizers. As more individuals are diagnosed with COPD, the need for effective management and treatment options grows. Respiratory devices are essential in providing symptomatic relief, improving lung function, and enhancing the quality of life for COPD patients. Additionally, increased awareness and early diagnosis of COPD further drive the adoption of these devices, boosting market growth.
Restraint:
Risk of side effects and complications
The risk of side effects and complications in respiratory devices, such as infections, airway irritation, or device-related injuries, stems from improper use, device malfunctions, or lack of proper maintenance. These risks can lead to adverse patient outcomes and diminished effectiveness of treatment. Additionally, regulatory scrutiny and the need for extensive clinical trials to address these risks can slow down the introduction of new devices, further hampering market expansion.
Opportunity:
Expansion and improvement of healthcare facilities
As hospitals and clinics upgrade their infrastructure, they are more likely to invest in state-of-the-art respiratory devices to enhance patient care. Improved healthcare facilities also lead to better diagnosis and treatment of respiratory conditions, driving demand for devices like ventilators, oxygen therapy equipment, and monitoring systems. Additionally, expanding healthcare services in emerging markets brings respiratory devices to previously underserved populations; further boosting market growth and ensuring better respiratory health management globally.
Threat:
High treatment costs
High treatment costs for respiratory devices arise from the advanced technology, manufacturing complexities, and ongoing maintenance associated with these devices. Expensive components and research & development investments contribute to elevated prices. Consequently, this financial barrier hampers market growth by restricting the potential customer base and slowing down the penetration of new technologies into underserved areas. Limited affordability also impacts overall market expansion and equitable healthcare access.
Covid-19 Impact
The covid-19 pandemic significantly impacted the respiratory devices market, driving unprecedented demand for ventilators, oxygen therapy devices, and other respiratory support equipment. The surge in covid-19 cases overwhelmed healthcare systems globally, leading to shortages and increased production of these devices. Manufacturers rapidly scaled up production to meet the urgent need. Additionally, the pandemic raised awareness of respiratory health, potentially leading to sustained demand for respiratory devices even post-pandemic, as healthcare systems prepare for future respiratory crises and individuals prioritize respiratory wellness.
The monitoring devices segment is expected to be the largest during the forecast period
The monitoring devices segment is estimated to have a lucrative growth. Respiratory monitoring devices are crucial for assessing and managing respiratory health. They include pulse oximeters, capnographs, and spirometers. These devices provide real-time data, enabling timely interventions and personalized treatment plans. With advancements in technology, portable and user-friendly monitoring devices are becoming increasingly accessible, enhancing patient care and outcomes.
The asthma segment is expected to have the highest CAGR during the forecast period
The asthma segment is anticipated to witness the highest CAGR growth during the forecast period. Respiratory devices for asthma are essential in managing and alleviating symptoms of this chronic respiratory condition. These devices improve medication adherence, offer precise dosage, enhance symptom management, and enable timely intervention during asthma attacks. By facilitating better control of asthma symptoms, these devices contribute to improved quality of life, reduced frequency of exacerbations, and minimized reliance on emergency care.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period due to increasing prevalence of respiratory diseases, rising pollution levels, and a growing aging population. Countries like China and India are significant contributors, driven by large patient populations and expanding healthcare infrastructure. Technological advancements and government initiatives to improve healthcare access further boost market growth. The COVID-19 pandemic has also heightened demand for respiratory support devices in the region. As awareness of respiratory health increases, the market is expected to see sustained expansion in the coming years.
Region with highest CAGR:
North America respiratory devices market is well-established and driven by high prevalence of respiratory conditions such as COPD and asthma. Advanced healthcare infrastructure, significant healthcare spending, and widespread adoption of cutting-edge technologies contribute to market growth. Increasing awareness about respiratory health, coupled with a growing elderly population, bolsters market expansion. The U.S. dominates the market due to extensive research and development activities, favourable reimbursement policies, and strong presence of major medical device manufacturers.
Key players in the market
Some of the key players profiled in the Respiratory Devices Market include Inogen, Inc., ResMed Inc., Medtronic plc, Fisher & Paykel Healthcare Corporation Limited, Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo Corporation, Koninklijke Philips N.V., Invacare Corporation, Air Liquide Medical Systems, Hamilton Medical AG, Vyaire Medical, Inc., Getinge AB, Nihon Kohden Corporation, Smiths Medical, DeVilbiss Healthcare LLC, Asahi Kasei Corporation and Teleflex Incorporated.
Key Developments:
In August 2023, GE Healthcare launched new wireless patient monitoring device, the CARESCAPE™ Remote Monitoring (RM) system. This advanced device is designed to enhance patient care by providing continuous, real-time monitoring of patients' vital signs without the need for wired connections.
In April 2021, Smiths Medical launched the Acapella choice blue vibratory positive expiratory pressure (PEP) therapy system. Acapella is designed to aid in the removal of secretions for patients who have cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
Product Types Covered:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables & Accessories
Disease/Disorders Covered:
• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Cystic Fibrosis
• Neonatal Respiratory Distress Syndrome
• Other Respiratory Disorders
End Users Covered:
• Hospitals
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Respiratory Devices Market, By Product Type
5.1 Introduction
5.2 Therapeutic Devices
5.2.1 PAP Devices
5.2.1.1 CPAP Devices
5.2.1.2 APAP Devices
5.2.1.3 BiPAP Devices
5.2.2 Ventilators
5.2.2.1 ICU Ventilators
5.2.2.2 Portable/Transportable Ventilators
5.2.3 Nebulizers
5.2.4 Humidifiers
5.2.5 Oxygen Concentrators
5.2.5.1 Fixed Oxygen Concentrators
5.2.5.2 Portable Oxygen Concentrators
5.2.6 Inhalers
5.2.7 Other Therapeutic Devices
5.3 Monitoring Devices
5.3.1 Pulse Oximeters
5.3.2 Capnographs
5.3.3 Spirometers
5.3.4 Polysomnography Devices
5.3.5 Peak Flow Meters
5.3.6 Other Monitoring Devices
5.4 Diagnostic Devices
5.4.1 Spirometry Systems
5.4.2 Pulmonary Function Testing Equipment
5.4.3 Blood Gas Analyzers
5.4.4 Oximetry Equipment
5.4.5 Other Diagnostic Devices
5.5 Consumables & Accessories
5.5.1 Masks
5.5.2 Breathing Circuits
5.5.3 Nebulizer Cups
5.5.4 Oxygen Tubing
5.5.5 Filters
5.5.6 Other Consumables & Accessories
6 Global Respiratory Devices Market, By Disease/Disorder
6.1 Introduction
6.2 Acute Respiratory Failure
6.3 Chronic Obstructive Pulmonary Disease (COPD)
6.4 Asthma
6.5 Sleep Apnea
6.6 Cystic Fibrosis
6.7 Neonatal Respiratory Distress Syndrome
6.8 Other Respiratory Disorders
7 Global Respiratory Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Homecare Settings
7.4 Ambulatory Surgical Centers (ASCs)
7.5 Specialty Clinics
7.6 Other End Users
8 Global Respiratory Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Inogen, Inc.
10.2 ResMed Inc.
10.3 Medtronic plc
10.4 Fisher & Paykel Healthcare Corporation Limited
10.5 Drägerwerk AG & Co. KGaA
10.6 GE Healthcare
10.7 Masimo Corporation
10.8 Koninklijke Philips N.V.
10.9 Invacare Corporation
10.10 Air Liquide Medical Systems
10.11 Hamilton Medical AG
10.12 Vyaire Medical, Inc.
10.13 Getinge AB
10.14 Nihon Kohden Corporation
10.15 Smiths Medical
10.16 DeVilbiss Healthcare LLC
10.17 Asahi Kasei Corporation
10.18 Teleflex Incorporated
List of Tables
1 Global Respiratory Devices Market Outlook, By Region (2022-2030) ($MN)
2 Global Respiratory Devices Market Outlook, By Product Type (2022-2030) ($MN)
3 Global Respiratory Devices Market Outlook, By Therapeutic Devices (2022-2030) ($MN)
4 Global Respiratory Devices Market Outlook, By PAP Devices (2022-2030) ($MN)
5 Global Respiratory Devices Market Outlook, By Ventilators (2022-2030) ($MN)
6 Global Respiratory Devices Market Outlook, By Nebulizers (2022-2030) ($MN)
7 Global Respiratory Devices Market Outlook, By Humidifiers (2022-2030) ($MN)
8 Global Respiratory Devices Market Outlook, By Oxygen Concentrators (2022-2030) ($MN)
9 Global Respiratory Devices Market Outlook, By Inhalers (2022-2030) ($MN)
10 Global Respiratory Devices Market Outlook, By Other Therapeutic Devices (2022-2030) ($MN)
11 Global Respiratory Devices Market Outlook, By Monitoring Devices (2022-2030) ($MN)
12 Global Respiratory Devices Market Outlook, By Pulse Oximeters (2022-2030) ($MN)
13 Global Respiratory Devices Market Outlook, By Capnographs (2022-2030) ($MN)
14 Global Respiratory Devices Market Outlook, By Spirometers (2022-2030) ($MN)
15 Global Respiratory Devices Market Outlook, By Polysomnography Devices (2022-2030) ($MN)
16 Global Respiratory Devices Market Outlook, By Peak Flow Meters (2022-2030) ($MN)
17 Global Respiratory Devices Market Outlook, By Other Monitoring Devices (2022-2030) ($MN)
18 Global Respiratory Devices Market Outlook, By Diagnostic Devices (2022-2030) ($MN)
19 Global Respiratory Devices Market Outlook, By Spirometry Systems (2022-2030) ($MN)
20 Global Respiratory Devices Market Outlook, By Pulmonary Function Testing Equipment (2022-2030) ($MN)
21 Global Respiratory Devices Market Outlook, By Blood Gas Analyzers (2022-2030) ($MN)
22 Global Respiratory Devices Market Outlook, By Oximetry Equipment (2022-2030) ($MN)
23 Global Respiratory Devices Market Outlook, By Other Diagnostic Devices (2022-2030) ($MN)
24 Global Respiratory Devices Market Outlook, By Consumables & Accessories (2022-2030) ($MN)
25 Global Respiratory Devices Market Outlook, By Masks (2022-2030) ($MN)
26 Global Respiratory Devices Market Outlook, By Breathing Circuits (2022-2030) ($MN)
27 Global Respiratory Devices Market Outlook, By Nebulizer Cups (2022-2030) ($MN)
28 Global Respiratory Devices Market Outlook, By Oxygen Tubing (2022-2030) ($MN)
29 Global Respiratory Devices Market Outlook, By Filters (2022-2030) ($MN)
30 Global Respiratory Devices Market Outlook, By Other Consumables & Accessories (2022-2030) ($MN)
31 Global Respiratory Devices Market Outlook, By Disease/Disorder (2022-2030) ($MN)
32 Global Respiratory Devices Market Outlook, By Acute Respiratory Failure (2022-2030) ($MN)
33 Global Respiratory Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2022-2030) ($MN)
34 Global Respiratory Devices Market Outlook, By Asthma (2022-2030) ($MN)
35 Global Respiratory Devices Market Outlook, By Sleep Apnea (2022-2030) ($MN)
36 Global Respiratory Devices Market Outlook, By Cystic Fibrosis (2022-2030) ($MN)
37 Global Respiratory Devices Market Outlook, By Neonatal Respiratory Distress Syndrome (2022-2030) ($MN)
38 Global Respiratory Devices Market Outlook, By Other Respiratory Disorders (2022-2030) ($MN)
39 Global Respiratory Devices Market Outlook, By End User (2022-2030) ($MN)
40 Global Respiratory Devices Market Outlook, By Hospitals (2022-2030) ($MN)
41 Global Respiratory Devices Market Outlook, By Homecare Settings (2022-2030) ($MN)
42 Global Respiratory Devices Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
43 Global Respiratory Devices Market Outlook, By Specialty Clinics (2022-2030) ($MN)
44 Global Respiratory Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
